Ro

OTC products · Product label record

Rohto Optic Glow drug information

NAPHAZOLINE HYDROCHLORIDE, POVIDONE, PROPYLENE GLYCOL
The Mentholatum Company · OPHTHALMIC

Product NDC: 10742-8160

Join the community
CommunityExperiencesReviewsDrug database
Source label information, not individualized medical advice. This record applies to the product and labeler shown below. Compare the exact formulation, strength and country with your package and the current source label.
Generic nameNAPHAZOLINE HYDROCHLORIDE, POVIDONE, PROPYLENE GLYCOL
Labeler / manufacturerThe Mentholatum Company
RouteOPHTHALMIC
Drug classDrug class not supplied in source label
Product NDC10742-8160
Label effective date2026-08-20

Official product label reference

Rohto Optic Glow — The Mentholatum Company

This page contains 12 source sections for NAPHAZOLINE HYDROCHLORIDE, POVIDONE, PROPYLENE GLYCOL, ophthalmic route. Label set df9c5f7c-96e6-4b2b-b8cb-21a6a3342dff, version 10.

Retrieved 2026-10-02 · openFDA dataset updated 2026-10-02 · Check the current DailyMed label

Label records can cover multiple strengths or package sizes. A label listing does not by itself establish FDA approval or current market availability. Check the source and application history for this specific product.

Uses described in the label

Uses relieves redness of the eye due to minor eye irritations temporarily relieves burning and irritation due to dryness of the eye

Purpose

Purpose Naphazoline hydrochloride - Redness reliever Povidone – Lubricant Propylene glycol - Lubricant
Dosage and administration — label text
Directions put 1 or 2 drops in the affected eye(s) up to 4 times daily tightly snap on cap to seal Other Safety Information do not store above 25°C (77°F)
Warnings and precautions
When using this product do not touch tip of container to any surface to avoid contamination replace cap after each use do not use if solution changes color or becomes cloudy overuse of this product may produce increased redness of the eye pupils may become enlarged temporarily
Warnings
Warnings For external use only Ask a doctor before use if you have narrow angle glaucoma When using this product do not touch tip of container to any surface to avoid contamination replace cap after each use do not use if solution changes color or becomes cloudy overuse of this product may produce increased redness of the eye pupils may become enlarged temporarily Stop use and ask a doctor if you experience eye pain changes in vision occur redness or irritation of the eyes lasts condition worsens or lasts more than 72 hours Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.
Active ingredient
Active ingredients Naphazoline hydrochloride 0.03% Povidone 0.5% Propylene glycol 0.2%
Ask a doctor before use
Ask a doctor before use if you have narrow angle glaucoma
When to stop use and seek help
Stop use and ask a doctor if you experience eye pain changes in vision occur redness or irritation of the eyes lasts condition worsens or lasts more than 72 hours
Child safety
Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.
Other safety information
Other Safety Information do not store above 25°C (77°F)
Inactive ingredient
Inactive ingredients anhydrous citric acid, boric acid, chlorobutanol, edetate disodium, menthol, polysorbate 80, potassium aspartate, purified water, pyridoxine hydrochloride, sodium borate, sodium citrate, sodium hyaluronate
Questions
Questions? 1-877-636-2677 MON-FRI 9 AM to 5 PM (EST)

Official sources and product identifiers

Substances listed: NAPHAZOLINE HYDROCHLORIDE, POVIDONE, UNSPECIFIED, PROPYLENE GLYCOL

RxNorm identifiers: 2531299

Package NDC codes

10742-8160-1

Further research and background

These are external searches for related information. Research, encyclopedia and news articles have not been imported into this product record.

Coverage and corrections

The text is extracted from a US structured product label. Tables are represented as text where supplied; formatting and illustrations may be lost. A missing section does not mean a risk is absent. This reference has not been independently reviewed by a clinician and is not a live safety-alert service.

Source retrieved 2026-10-02. Read the source policy.